and lexA) was obtained from the University of Auckland, New Zealand (c/o Dr. L. FERGUSON). A slow-growing variant of this organism was subsequently isolated, designated as E. coil CM871NZ, and was used as the assay organism. A wild type strain, WP2NZ, was used as a control.
The screening system was carried out as a disk test. Thus, the fermentation samples were disked on a plate seeded with the test organism. For control, an agar plate seeded with the wild type strain, E. coil WP2NZ was disked with the same fermentation samples.
The agar plating medium included an agar base layer and a soft-agar overlay. The base agar consisted of K2HPO4 0.7 %, KH2PO4 0.3 %, sodium citrate 0.094 %, MgSO4.7H2O 0.01 %, (NH4)2SO4 0.1%, dextrose 2%, casein hydrolysate 5%, L-tryptophan 0.2%, and agar 1.5%. The pH was adjusted to 7.3 before autoclaving. Glucose, casein hydrolysate and L-tryptophan were sterilized separately. The soft-agar overlay consisted of agar 1.0%.
The assay plate was prepared by pouring 30 ml of the molten base agar onto a 150 x 25 mm (LabTek) Petri plate; after it was solidified, 10 ml of the soft-agar seeded with the organism were evenly overlayed. Paper disks (12.7 mm) dipped in the fermentation beers were laid onto the plate and the plate was incubated overnight at 37°C. Fermentation samples considered positive in the test showed inhibition zones versus E. coli CM871NZ at least 4 mm larger than the zones in the control E. coil WP2NZ. 
Culture Characterization
The culture was isolated from a soil collected in St. Thomas, Virgin Islands. The soil was plated on a modified Lindenbein medium.4) Culture characterization was carried out following the ISP procedure.5) In addition CIM-23 medium6) was used. Cell wall and whole cell analyses were carried out following the procedure of BECKER et al.7) and LECHEVALIER,8) respectively. Fermentation Stock cultures of the organism were maintained in lyophilized vials, and working cultures stored as cryovials in liquid nitrogen refrigerator (Union Carbide, Indianapolis). To start a fermentation, the contents of a thawed cryovial was used to inoculate a 300-ml seed flask (Bellco, Shallow baffle) containing 50 ml of seed medium. The seed medium consisted of 0.5 % yeast hydrolysate (Amberex 1003, Amber Labs.), Cerelose 0.1 %, dextrin (Amidex B411, Corn Products) 2.4 %, hydrolyzed peptone (N-Z case, Humko-Sheffield) 0.5% spray-dried meat solubles (Daylin Labs.) 0.3% and CaCO3 0.2%.
The production of the antibiotic was carried out in 300-ml shake-flasks, 30-liter stirred jars, or in 760-liter fermentors. The production medium consisted of maltose (Eastern Chem.) 2.5%, distillers solubles (Grain Processing) 0.5 %, safflower meal (PVO International) 0.75 %, torula yeast (Rhinelander Paper Co.) 0.2% NaCl0.1 % and CaCO3 0.25%. The fermentation conditions were as follows : shakeflask, 50 ml/300-ml flask, 200 rpm shaker speed (Model G-53 New Brunswick Co.); 30-liter stirredjar, 16 liters/jar 1 vol/vol/minute air, 300 rpm; and 760-liter fermentor, 600 liters/tank, 0.75 vol/vol/ minute air, 155 rpm. The fermentations were carried out for 72 hours at 33°C.
Assay and Antitumor Activity The antibiotic was assayed by both inhibition zone versus E. coli CM871NZ and by high pressure liquid chromatography (HPLC). The HPLC assay method involved a 4.1 (ID) x 250 mm PRP-1 column (Hamilton Co., Reno) and a mobile phase consisting of a linear gradient form of 0.025 M, pH 9.5, borate buffer -acetonitrile -methanol (90 : 5 : 5) at time zero, to 0.025 M, pH 9.5, borate bufferacetonitrile -methanol (70 : 25 : 5) over a course of seven minutes at a flow rate of 2.0 ml/minute. The retention time of the antibiotics in this system was 3.5 minutes.
The in vivo antitumor activity was evaluated versus P388 murine lymphocytic leukemia tumor cell line in CDF, mice.9) The tumor cells were injected intraperitoneally (ip) on day 0, and the antibiotic was administered ip on day I through 9.
Antimicrobial Activity The antimicrobial activity of the compound was evaluated by the broth dilution method.10) Because of the poor water solubility, the antibiotic was dissolved in methanol then diluted with distilled water to bring the final solvent concentration to 10%. Subsequent dilutions were made in the media previously dispensed in the microdilution trays.
Results

Morphological and Cultural Characteristics
Whole cell and cell wall analyses revealed LL-2,6-diaminopimelic acid (L-DAP) and glycine with no characteristic sugars. The organism produced aerial and substrate mycelia typical of Streptomyces.
The growth characteristics of the organism on different media is shown on Table 1 , carbon utilization on Table 2 , and physiological properties on Table 3 . In reviewing the literature, some of these characteristics resembled Streptomyces lomondensis NRRL 3252.11) For this reason side-by-side comparative studies were carried out for the two organisms. Some notable differences include spore chain morphology, spore wall ornamentation (Fig. 2) , nitrate reduction, and production of soluble pigments (Table 4) .
Fermentation
The fermentation pattern of the organism in a 756-liter fermentor is shown in Table 5 . The pro- in the L1210 tissue culture screen. This indicates the feasibility and effectivity of a microbial system as a front line screen for antitumor compounds. A purified PD 116,152, however, showed cytotoxicity versus L1210 in tissue culture (ID50 0.17 ,ug/ml) but still considerably less than CI-92012) (ID50 0.073 ug/ml) or CI-94013) (ID50 0.12 ng/ml). PD 116,152 showed a very narrow antimicrobial spectrum with excellent activity versus S. pneumoniae and marginal activity versus other microorganisms.
Other phenazine type antibiotics, lomofungin2) and 1,6-dihydroxy-2-chlorophenazine14) have shown potent and broad antimicrobial activities. The main differences of the above antibiotics from PD 116,152 are certain side groups, indicating the amenability of the compound to structural modification and corresponding changes in biological activity. 
